The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis

Mehri Khatami1, Mohammad Mehdi Heidari1, Reza Mansouri2

  • 1Department of Biology, Faculty of Science, Yazd University, Yazd, Iran.

Abstract

Insights

This study found no link between the POLG gene

Area of Science:

  • Neuroscience and Genetics
  • Mitochondrial DNA Replication and Disease

Background:

  • Multiple Sclerosis (MS) involves inflammatory and neurodegenerative processes impacting the central nervous system.
  • Mitochondrial dysfunction is a suspected factor in neurodegenerative disorders like MS.
  • The DNA polymerase-gamma (POLG) gene, crucial for mtDNA replication, has a poly-Q tract influenced by CAG trinucleotide repeats.

Purpose of the Study:

  • To investigate the association between POLG gene CAG trinucleotide repeat length and Multiple Sclerosis (MS) in an Iranian population.
  • To explore the potential role of POLG gene variations in the pathogenesis of MS.

Main Methods:

  • Polymerase Chain Reaction - Single Strand Conformation Polymorphism (PCR-SSCP) analysis was employed.
  • The study analyzed POLG trinucleotide repeats in 40 Iranian MS patients and 47 healthy controls.
  • Participants were age, gender, and ethnically matched.

Main Results:

  • The most frequent allele observed in MS patients was 10 CAG repeats (10Q).
  • Alleles with 11 and 12 CAG repeats were also detected.
  • No statistically significant difference in CAG repeat length distribution was found between MS patients and healthy controls.

Conclusions:

  • The CAG repeat polymorphism in the POLG gene does not appear to be correlated with the pathogenesis of Multiple Sclerosis.
  • Other types of mutations within the POLG gene might play a more significant role in MS development.
  • Further research into diverse POLG gene mutations is warranted for understanding MS pathogenesis.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
78
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
158
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
23.3K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
162.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K